Navigation Links
Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results

k cancer, and a Phase I/II trial for breast cancer. Inovio's technology is protected by an extensive patent portfolio covering in vivo electroporation. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our plans to develop our electroporation drug and gene delivery technology. Actual events or results may differ from our expectations as a result of a number of factors, including the uncertainties inherent in clinical trials and product development programs (including, but not limited to, the fact that pre-clinical results referenced in this release may not be indicative of results achievable from testing in humans), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of Inovio's technology as a delivery mechanism, the availability or potential availability of alternative therapies or treatments for the conditions targeted by Inovio or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that Inovio and its collaborators hope to develop, evaluation of potential opportunities, issues involving patents and whether they or licenses to them will provide Inovio with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether Inovio can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of our technology by potential corporate or other partners or collaborators, capital market conditions, and other factors set forth in the our Annual Report on Form 10-K for the year ended December 31, 2006 and other regulatory filings. There can be no assurance that any product in our product pipeline will be succe
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
2. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
3. Inovio: DNA delivery technology shows positive human results
4. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
5. Inovio Biomedicals DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
6. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
10. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
11. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
Post Your Comments:
(Date:10/1/2014)... , Switzerland , October 1, 2014 ... in Clinical Genomics and Next Generation Sequencing (NGS) data ... clinicians to run full cystic fibrosis analysis in a ... identification and characterisation of all types of variants in ... Until now, it has not been possible ...
(Date:9/30/2014)... 30, 2014 This report analyzes the worldwide markets ... Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. ... Canada, Japan , Europe ... , and Rest of World. Annual estimates and forecasts ... six-year historic analysis is provided for these markets. ...
(Date:9/30/2014)... Mass. , Sept. 30, 2014  Hologic, Inc. ... Stephen MacMillan , Hologic,s President and Chief Executive Officer, ... Ceremony on October 1, the first day of Breast ... discuss the Company,s campaign focused on the important benefits ... approved by the FDA as clinically superior to traditional ...
Breaking Medicine Technology:Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
(Date:10/1/2014)... 2014 Phoseon Technology, the pioneer in ... expand the business worldwide. This rapid growth includes increased ... for manufacturing efforts. The company has experienced average annual ... and expects this growth to continue in the future ... worldwide adoption. , “We are very pleased that ...
(Date:10/1/2014)... from Duke Medicine suggests that some people who are ... hard-wired to gain weight when exposed to chronic stress, ... 13 percent of people, all of whom are Caucasian, ... help them reduce heart disease with simple interventions such ... "Genetic susceptibility, psychosocial stress and metabolic factors act in ...
(Date:10/1/2014)... Diet Doc understands that many of their clients have ... dieting attempts could be easily sabotaged by the temptation to ... into their programs as a way to control the ... weight loss results, it also allows patients to stick with ... weight for the future. , Earlier versions of the hormone ...
(Date:10/1/2014)... 2014 On Sept. 9, Chapín Coffee ... the Martha Stewart American Made Awards (MSAMAs), an annual ... country in the fields of crafts, design, food and ... a finalist in the MSAMAs, which celebrates entrepreneurs and ... improving local communities and changing the way we shop, ...
(Date:10/1/2014)... WOODLAND HILLS, CA (PRWEB) October 01, 2014 ... Mamaly Reshad will speak to a group of dental ... week in the northern Spain city of Oviedo. Dr. ... known prosthodontist and lecturer with clients on two continents, ... mouth complex and aesthetic full mouth reconstruction. , “These ...
Breaking Medicine News(10 mins):Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4
... Joel T. Allison, FACHE, president/CEO of Baylor Health Care ... of the Texas Hospital Association,s Earl M. Collier Award ... Collier Award is the highest honor bestowed by THA. ... annual Leadership Conference in Austin."Joel Allison exemplifies the leadership ...
... 22 ATS Medical, Inc.,(Nasdaq: ATSI ... and services, today announced its participation in the ... (STS) and related,company-sponsored events. The meeting runs ... as one of the year,s key gatherings of,cardiovascular ...
... School of Medicine have discovered how a whole class ... Their findings, reported online this week at the ... Edition, suggest that a subgroup of cancer patients might ... of chemotherapeutics doxorubicin (Adriamycin), daunorubicin, epirubicin, idarubicin ...
... N.C., Jan. 22 Nearly 2,500 dentists, dental,hygienists, dental ... take part in the sixth annual national "Give Kids ... to be among the largest events of its kind,in ... other dental professionals will volunteer their time at,designated dental ...
... Recovery Group, Inc. (IRG) announce the formation of Impairment Resources, ... assure accurate and reliable impairment ratings. Impairment Resources will combine ... of the AMA Guides to the Evaluation of Permanent Impairment, ... ...
... fuel rise in employee engagementMINNEAPOLIS, Jan. 22 ... productivity solutions grew in 2008, due to ... incentives. HealthFitness (NYSE Alternext US: FIT) is ... and fitness management solutions for on-site and ...
Cached Medicine News:Health News:Allison Honored with Hospital Association's Highest Award 2Health News:Allison Honored with Hospital Association's Highest Award 3Health News:ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting 2Health News:ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting 3Health News:ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting 4Health News:How chemotherapy drugs block blood vessel growth, slow cancer spread 2Health News:How chemotherapy drugs block blood vessel growth, slow cancer spread 3Health News:North Carolina Dentists Team Up To Treat Needy Children 2Health News:Brigham and Associates and Insurance Recovery Group Launch Impairment Resources, a Joint Venture to Address Impairment Ratings 2Health News:Brigham and Associates and Insurance Recovery Group Launch Impairment Resources, a Joint Venture to Address Impairment Ratings 3Health News:Biometric Screening, Health Coaching and HRA Participation Grows in 2008 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: